Navigation Links
Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
Date:9/5/2012

SUNNYVALE, Calif., Sept. 5, 2012 /PRNewswire/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today reported financial results and recent developments for its fiscal year and fourth quarter ended June 30, 2012.

Financial Results for Fiscal Year and Fourth Quarter Ended June 30, 2012The non-GAAP (Generally Accepted Accounting Principles) net income reported for the fiscal year ended June 30, 2012 was $21.9 million, or $0.32 and $0.30 per basic and diluted earnings per share, respectively. This compares with a non-GAAP net loss of $28.0 million, or $0.47 loss per share, for the fiscal year ended June 30, 2011. For the quarter ended June 30, 2012, the non-GAAP net loss was $15.1 million, or $0.22 loss per share, which compares with a non-GAAP net loss of $9.1 million, or $0.15 loss per share for the 2011 quarter. See "Use of Non-GAAP Financial Measures" below for a description of our Non-GAAP measures. Reconciliation between certain GAAP and non-GAAP measures is provided at the end of this press release.

The GAAP net income for the fiscal year ended June 30, 2012 was $12.0 million, or $0.17 per basic and diluted earnings per share.  This compares with a GAAP net loss of $35.2 million, or $0.59 loss per share for the year ended June 30, 2011.  For the quarter ended June 30, 2012, the GAAP net loss was $16.9 million, or $0.24 loss per share. This compares with a GAAP net loss of $11.0 million, or $0.18 loss per share for the fiscal quarter ended June 30, 2011.

Revenue for the fiscal year ended June 30, 2012 was $82.0 million, compared to $8.2 million for the fiscal year ended June 30, 2011, an increase of $73.8 million. Revenue for the quarter ended June 30, 2012 was $2.1 million, compared to $1.4 million for the quarter ended June 30, 2011, an increase of $0.7 million.

At June 30, 2012, the Company had cash, cash equivalents and marketable securit
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
2. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
7. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
8. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
9. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
10. Luminex Corporation Reports First Quarter 2012 Results
11. Hospira Reports First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , September 23, 2014 ... has announced the addition of the  "Large ... to their offering.  ,     ... drug delivery market holds significant potential for ... vials and painful needles to the modern-day ...
(Date:9/23/2014)... SAN FRANCISCO , Sept. 23, 2014  SiteOne ... round of equity financing. Led by Sears Capital Management ... and Joe Zakrzewski , the $1.5 million financing ... inhibitor program for pain and to further develop its ... other pain indications. In conjunction with the ...
(Date:9/23/2014)... September 23, 2014 According ... by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), ... Orthopedics) - Global Forecasts to 2019", published by ... forecast period of 2014 to 2019. The market ... at CAGR of 9.6% from 2014 to 2019. ...
Breaking Medicine Technology:Large Volume Wearable Injectors - 2nd Edition 2Large Volume Wearable Injectors - 2nd Edition 3Large Volume Wearable Injectors - 2nd Edition 4Large Volume Wearable Injectors - 2nd Edition 5SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 2SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 3Ablation Technologies Market Worth $3.81 Billion by 2019 2Ablation Technologies Market Worth $3.81 Billion by 2019 3Ablation Technologies Market Worth $3.81 Billion by 2019 4
... Oct. 12, 2011 Reportlinker.com announces that ... in its catalogue: ... Region 2010-2014 ... the Peripheral Vascular Devices market in the ...
... (NYSE: BSX ) will webcast its conference call ... 2011 on Thursday, October 20, at 8:00 a.m. ET. ... becomes Boston Scientific,s Chief Executive Officer on October 17, and ... A live webcast of the conference call will be ...
Cached Medicine Technology:Peripheral Vascular Device Market in the APAC Region 2010-2014 2Boston Scientific To Webcast Conference Call Discussing Third Quarter 2011 Financial Results 2
(Date:9/23/2014)... (PRWEB) September 23, 2014 AttorneyOne.com, a ... all the latest information from the FDA on ... 5, that its Private Label Jalapeno Bagels are recalled ... stones. Publix Jalapeno Bagels were sold in ... department. , Taking into consideration the latest developments, ...
(Date:9/23/2014)... 23, 2014 (HealthDay News) -- A test used to diagnose ... where certain lung infections are more common, a new analysis ... is through the use of what,s known as functional imaging. ... FDG-PET is used, according to the study authors. Cancerous ... parts of the lungs that don,t have cancer, according ...
(Date:9/23/2014)... Grinnell Mutual seeks submissions from the public ... Working Together Making It Better will provide grants ... positively impacting their communities. , “So many people ... a better places,” said Grinnell Mutual ... “Their leadership—as coaches, as volunteers, as mentors—help to ...
(Date:9/23/2014)... who are already obese as teenagers could grow up ... peers of normal weight. So says Petter Lundborg of ... Rooth of Linneas University and Lund University, all in ... United Kingdom and the United States, and the results ... , The researchers analyzed large-scale data of 145,193 Swedish-born ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 ... allergic rhinitis (AR) is highly fragmented, with ... SIT formulations available, under different regulatory restrictions, ... markets. Europe has the most developed market, ... and allergen immunotherapy tablets (AITs) all being ...
Breaking Medicine News(10 mins):Health News:Publix Private Label Jalapeno Bagels Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Lung Infections May Hamper Ability to Detect Lung Cancer 2Health News:Grinnell Mutual Invites Submissions for Innovative, Collaborative Local Projects in Its Second Annual Working Together Making It Better Promotion 2Health News:Note to young men: Fat doesn't pay 2Health News:Allergen extract Allergic Rhinitis Specific Immunotherapy Market to Grow $688.3m by 2018 Says a New Report Available at MarketOptimizer.org 2Health News:Allergen extract Allergic Rhinitis Specific Immunotherapy Market to Grow $688.3m by 2018 Says a New Report Available at MarketOptimizer.org 3Health News:Allergen extract Allergic Rhinitis Specific Immunotherapy Market to Grow $688.3m by 2018 Says a New Report Available at MarketOptimizer.org 4
... and community for decades, PHILADELPHIA, Nov. 11 ... leading health insurer, turns 70,years old. While health ... 1938, experts agree that access to affordable,quality health ... was a key,consideration when millions cast their vote ...
... Introducing ReBound(TM) the Revolution in Thermotherapy, ALAMEDA, ... and,ReGear Life Sciences announced today the introduction of ... to treat pain, muscle,spasms, and joint contractures using ... for providing state-of-the-art injury treatment systems,to the physical ...
... triglycerides throughout the body , , TUESDAY, Nov. 11 (HealthDay ... the risk of high blood pressure in women who ... of a new study by U.S. researchers who analyzed ... Study. , Lipoprotein particles carry cholesterol and triglycerides throughout ...
... walls as thick as that of a middle-aged person ... days are 13 going on 45, at least when ... presented Tuesday at the American Heart Association,s annual scientific ... representative of someone three decades older. , "These data ...
... NEW YORK, Nov. 11 Today, the ... the results of a,nationwide survey on the ... "Unfortunately, APIC failed to connect the dots,",says ... to Reduce Infection,Deaths (RID). "The new data ...
... 11 Pam Kreager, Director of,Clinical Quality ... Term,Care Group, Inc. (LTCG), has been elected ... (LTCIF). The Long Term Care International Forum,( ... is to promote,efficiency, effectiveness and high standards ...
Cached Medicine News:Health News:Independence Blue Cross Celebrates 70 Years Of Service In Southeastern Pennsylvania 2Health News:Independence Blue Cross Celebrates 70 Years Of Service In Southeastern Pennsylvania 3Health News:Independence Blue Cross Celebrates 70 Years Of Service In Southeastern Pennsylvania 4Health News:Independence Blue Cross Celebrates 70 Years Of Service In Southeastern Pennsylvania 5Health News:Game Ready(TM) and ReGear Life Sciences(TM) Bring Innovative New Heat Therapy to Market 2Health News:Game Ready(TM) and ReGear Life Sciences(TM) Bring Innovative New Heat Therapy to Market 3Health News:Lipoprotein Levels May Predict Women's Hypertension Risk 2Health News:Obese Kids Have Old Arteries 2Health News:Obese Kids Have Old Arteries 3Health News:APIC Covers Up Extent and Causes of Deadly C. diff 2Health News:Long Term Care International Forum names LTCG's Pam Kreager as President 2
The original battery-operated suction and irrigation system features a new ergonomic hand piece and superior performance characteristics that have increased the overall flow rate....
... of both worlds, the PeaceKeeper 20 ... latest addition to the Wet-Field comprehensive ... instruments for ophthalmic surgery. Combining highly ... and backflush functionality in a single ...
...
...
Medicine Products: